BPC-157

Look, I need to be straight with you about something. There's been a real mix-up with this BPC-157 information, and honestly, I can't let you walk away confused. The content you've been reading talks about BPC-157 as a homeopathic tuberculosis nosode, but that's not what BPC-157 actually is. Know what I mean?

Here's the thing: BPC-157 is a 15-amino-acid peptide, not a homeopathic remedy. Research has explored it mainly in laboratory and animal studies, not as an established treatment for people. A 2025 systematic review found 35 preclinical studies and one human study in its musculoskeletal search.

What It Is

BPC-157 stands for "Body Protection Compound-157." FDA materials identify BPC-157 free base as a 15-amino-acid peptide sequence and describe acetate as a distinct form. Neither is a component of an FDA-approved drug.

Research interest does not establish a health benefit. A 2026 systematic review found only three human BPC-157 studies with 30 participants in total, covering knee pain, interstitial cystitis, and a two-person intravenous safety pilot. The studies were poor quality and the certainty of evidence was very low, so they do not establish benefit for tissue repair, digestive problems, or recovery. Read the systematic review.

Most published BPC-157 work is preclinical. Commercial books and online claims do not establish clinical benefit or safety. For the human evidence, read the 2026 systematic review, which found very low-certainty evidence from three small human studies.

What Research Has Examined

Animal and laboratory studies have examined BPC-157 in relation to tissue processes and inflammatory signaling. Those findings are hypothesis-generating; they do not show that BPC-157 supports repair mechanisms in people. The systematic review found that almost all included musculoskeletal studies were preclinical.

Digestive claims are not established in people. The small human evidence review included a study of interstitial cystitis, not gut healing, and it cannot show that BPC-157 repairs the intestinal barrier or treats digestive symptoms. The review's evidence summary rated the available human evidence very low certainty.

Animal models have reported outcomes relevant to muscle, tendon, ligament, bone, and wound repair, and laboratory studies have examined angiogenesis. The 2025 systematic review found 35 preclinical studies and one retrospective human knee-pain study; this is not clinical proof for tendon or ligament injuries, wounds, or neurological conditions. Read the review.

BPC-157 is an experimental, unapproved peptide rather than an FDA-approved prescription medicine or a traditional remedy. FDA says BPC-157 free base and acetate are not components of FDA-approved drugs. For compounded BPC-157, FDA identifies possible immunogenicity, peptide-impurity, and active-ingredient characterization concerns and says safety information for proposed routes is absent or limited. This guide does not endorse buying, compounding, injecting, or self-administering BPC-157. Read FDA's safety information.

How to Use It

There is no FDA-approved indication, established dose, or established route of administration for BPC-157. This guide provides no protocol and does not recommend self-experimentation. Symptoms, injuries, and illnesses should not be managed by substituting an unapproved peptide for appropriate evaluation or care. FDA's BPC-157 materials state that neither free base nor acetate is a component of an FDA-approved drug.

Human research is too limited to establish short- or long-term safety, interactions, safety in pregnancy or breastfeeding, or safety in children and people with health conditions. The only published intravenous pilot located in the review involved two prior BPC-157 recipients and reported no short-term adverse effects; it cannot establish general safety. Read the two-person pilot abstract.

BPC-157 is unrelated to Veratrum album and to homeopathic products. This page does not recommend one unproven product in place of another. Research interest in BPC-157 is not a basis for treating digestive symptoms or injuries.

For research purposes, traditional practices and experimental peptide research should be kept distinct. BPC-157 has no established traditional herbal or homeopathic use, and claims that it provides emotional, spiritual, or whole-body healing are not supported by the available clinical evidence. The human-evidence review found very low-certainty evidence from three small studies.

This is educational information for research only, not a treatment plan. BPC-157 does not replace diagnosis or appropriate care for injuries, persistent digestive symptoms, or other health concerns. Competitive athletes should also check their sport's anti-doping rules: WADA named BPC-157 as an example of a prohibited non-approved substance. Read WADA's notice.